Press Releases

UroMap Gene Expression Test Will Add to CareDx’s Best In Class Transplant Surveillance Comprehensive Solutions SOUTH SAN FRANCISCO, Calif. , May 05, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and

Strategically positioned for long-term growth and success SOUTH SAN FRANCISCO, Calif. , April 30, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value

Leaders in HLA and transplant laboratory solutions will present at CareDx virtual symposiums originally planned for EFI SOUTH SAN FRANCISCO, Calif. , April 27, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and

CareDx and Johns Hopkins Announce Mobile Health Partnership with RemoTraC Use Among Lung Transplant Patients SOUTH SAN FRANCISCO, Calif. , April 23, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA) and Johns Hopkins University , announced today the launch of the ALARM (AlloSure Lung Allograft

Leading transplant clinicians to present ten ISHLT accepted abstracts SOUTH SAN FRANCISCO, Calif. , April 22, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,

SOUTH SAN FRANCISCO, Calif. , April 21, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today

CareDx Announces Collaborations to Develop Cellular Therapy Diagnostics SOUTH SAN FRANCISCO, Calif. , April 14, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated,

CareDx Collaborates with ExamOne, a Quest Diagnostics Company, to Expand Mobile Phlebotomy Coverage Across the United States for Transplant Patients who are High Risk for COVID-19 SOUTH SAN FRANCISCO, Calif. , April 09, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision

SOUTH SAN FRANCISCO, Calif. , April 08, 2020 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high value healthcare solutions for transplant patients and caregivers, today

CareDx works with International Consortium of Transplant Leaders on a Global Registry of Transplant Patients Diagnosed with COVID-19 SOUTH SAN FRANCISCO, Calif. , April 06, 2020 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,